United States · FDA National Drug Code directory
Benzonatate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-8336_cb8266bf-7543-4ac4-aaea-086a497079f9
- Product NDC
- 68788-8336
- Form
- CAPSULE
- Composition / generic term
- Benzonatate
- Labeler
- Preferred Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230406
- Source listing expiry
- 20271231
Source-listed ingredients
- BENZONATATE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 15 CAPSULE in 1 BOTTLE (68788-8336-1) · 68788-8336-1
- 20 CAPSULE in 1 BOTTLE (68788-8336-2) · 68788-8336-2
- 30 CAPSULE in 1 BOTTLE (68788-8336-3) · 68788-8336-3
- 60 CAPSULE in 1 BOTTLE (68788-8336-6) · 68788-8336-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →